Manufacturing
Private Limited Company
250
Owned
30 Cr.
30
48.39 Cr.
63.11 Cr.
4.16 Cr.
3.68 Cr.
8.60
5.83%
Medical Gloves Manufacturer Company
Healthcare
Cochin, Kerala (India) 682001
4.15 Cr.
2005
67.00
Cochin SEZ , Kerala 682001
7014451513
info.bizzXchange@gmail.com
Raising Investment for expansion and to come out from NPA or 100 % takeover available
to come out from NPA declared as of April, 2025; no DRT/NCLT proceedings; OTS proposed with HDFC & Axis.
π Company Overview
Founded in 2005 and operating from the Cochin SEZ, Medical Clinical Care is a seasoned manufacturer of sterile and non-sterile clinical gloves with 20+ years of export experience. The company holds ISO 13485, CE-MDR certifications, and acquired US FDA registration, positioning itself as a leading OEM/whitelabel glove exporter to 24+ countries- France, Saudi Arabia, Russia, Israel, and Sri Lanka.
π Why Now? Indiaβs medical gloves industry is undergoing a structural transition:
β’ π Import substitution push: India's government now requires BIS/QCO certification for all medical gloves, displacing Chinese imports.
β’ π Global OEM buyers are shifting from China to India for reliability and compliance.
β’ π₯ Domestic glove demand in hospitals and pharma is rising ~11% CAGR, especially post-COVID.
β’ πΌ Scaled 3x in capacity (from 60K to 300K pairs gloves/day), fully operational and export-ready.
π° Capital Raise Proposal
Ask Details
Equity βΉ30 Cr for 26-30% stake (pre-money valua?on: βΉ98β120 Cr) buy-back option
NCD Mode NCD Route Private placements with Fixed Income % Coupon Rate with buy back option
Utilization:
o βΉ15 Cr β Working capital (raw material + cash conversion)
o βΉ7 Cr β OEM inventory buffer & trade finance
o βΉ5 Cr β D2C branding, Marketing & Branding
o βΉ3 Cr β Automation + packaging + ESG upgrades+ Sustainability
Compliance & Credit Strength
β’ β Overdue liabilities (per Experian, July 2025)
β’ β Secured assets incl. βΉ1.5 inventory, βΉ2.5 Cr payables (FY25)
β’ β Trademark registered (India), glove mould IP pending
β’ β Transparent MCA & ROC filings; GST compliant
π Strategic Benefits to Investors
β’ π Export-ready scale with buyers already in place
β’ π§€ First-mover advantage in Indiaβs QCO-based market
β’ πΌ Backed by 20 years of operating experience & certifications
β’ π° Attractive potential: ROCE > 17%, planned IPO/strategic buyout route by FY28
β’ πΈ Dividend pay-out model post FY26 (Optional)
more details avaible on interest
manufacturer of sterile and non-sterile clinical gloves